Glenmark Pharma reports 6% rise in Q4 consolidated net profit

29 May 2021 Evaluate

Glenmark Pharmaceuticals has reported results for fourth quarter and year ended March 31, 2021.

The company has reported 2.12% fall in its net profit at Rs 341.78 crore for the quarter under review as compared to Rs 349.19 crore for the same quarter in the previous year. However, total income of the company increased by 5.82% at Rs 1967.23 crore for Q4FY21 as compared Rs 1859.02 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported 6.15% rise in its net profit at Rs 233.87 crore for the quarter under review as compared to Rs 220.31 crore for the same quarter in the previous year. Total income of the company increased by 2.02% at Rs 2868.39 crore for Q4FY21 as compared Rs 2811.63 crore for the corresponding quarter previous year.

For the year ended March 31, 2021, the company has reported 21.77% rise in its net profit at Rs 1649.45 crore as compared to Rs 1354.55 crore for the previous year. Total income of the company increased by 8.81% at Rs 7964.17 crore for year under review as compared to Rs 7319.42 crore for year ended March 31, 2020.

For the year ended March 31, 2021, on the consolidated basis, the company has reported 25.02% rise in its net profit at Rs 970.09 crore as compared to Rs 775.97 crore for the previous year. Total income of the company increased by 1.79% at Rs 10994.15 crore for year under review as compared to Rs 10800.57 crore for year ended March 31, 2020.

Glenmark Pharma Share Price

1974.05 17.65 (0.90%)
12-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1794.30
Dr. Reddys Lab 1279.65
Cipla 1517.20
Zydus Lifesciences 929.05
Lupin 2114.10
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×